No Added Benefit From Revascularization in Low-Risk CAS ...Middle East

Medscape - News
Optimized medical therapy may be enough in patients with carotid artery stenosis who have a low to intermediate stroke risk, after the ESCT-2 trial showed no benefit from adding revascularization. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( No Added Benefit From Revascularization in Low-Risk CAS )

Apple Storegoogle play

Also on site :